Zura Bio files updated corporate presentation for investor meetings

Zura Bio Ltd

Updated corporate presentation dated September 4, 2025, filed as Exhibit 99.1.
Presentation highlights Zura Bio's dual-pathway biologic candidates in autoimmune/inflammatory diseases.
No specific clinical, financial, or guidance changes disclosed; presentation is a routine update.
Ticker ZURA is the sole identifier; no counterparties mentioned.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.